The diagnostics advisory committee considered evidence on KardiaMobile 6L for measuring QT interval from several sources, including an early value assessment report, cost and resource use report and ...
MOUNTAIN VIEW, Calif., Dec. 20, 2021 /PRNewswire/ -- AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced that KardiaMobile 6L, the most ...
ORLANDO, Fla.--(BUSINESS WIRE)--Today, GE Healthcare and AliveCor announced a partnership to deliver medical-grade six-lead electrocardiograms (ECGs) taken by patients on an AliveCor KardiaMobile 6L ...
KardiaMobile 6L Max is powered by advanced AI to offer a wider range of arrhythmia detection, more insights, and ongoing access to board-certified cardiologist ECG reviews. KardiaAlert is a ...
Data from AliveCor’s KardiaMobile 6L ECG, a portable ECG device that can detect AFib and other heart rhythm conditions, is viewable on a smart phone and sent to GE Healthcare’s MUSE cardiac management ...
With an eye toward helping those potentially suffering from COVID-19, Mountain View, Calif.-based Alivecor Inc. said its six-lead electrocardiogram (ECG), known as the Kardiamobile 6L, now is allowed ...
This section describes the evidence gaps, why they need to be addressed and their relative importance for future committee decision making. The committee will not be able to make a positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results